Psychedelic drug developer Compass Pathways is preparing to talk to the FDA about filing its psilocybin therapy COMP360 for approval in treatment-resistant depression (TRD), after reporting positive ...

Digital Science announces the launch of Compass by Dimensions, a dedicated publication impact tracking solution designed for ...

CPC review of 5,000 sales finds Compass at 29.7% to 39.5% share in five metros, raising double-ending and private listing ...

Space Compass and SWISSto12 have executed a procurement contract for the first GEO optical data relay satellite. This agreement represents a milestone toward the realisation of Space Compass’s optical ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Compass, Zillow, and eXp rolled out coming soon programs with different rules on exclusivity, MLS limits and lead routing.

NASHVILLE, Tenn., March 19, 2026 (GLOBE NEWSWIRE) -- The Costigan Group at Compass rolls out a structured pre-acquisition screening framework for short-term rental investors, giving buyers a ...

Space Compass Corporation ("Space Compass") and SWISSto12 SA ("SWISSto12") announced today that they have executed a procurement contract for the first GEO optical data relay satellite. This press ...

Investing.com - Stifel reiterated a Buy rating and $12.00 price target on Compass Therapeutics (NASDAQ:CMPX) shares, well above the current stock price of $5.10. The biotech company has delivered a ...

Austin-based fiduciary investment management and technology firm LeafHouse and Global Trust Company (GTC) on April 17 announced a strategic partnership to modernize collective investment trust (CIT) ...